DOP006 A Multicentre Cohort Study to Assess the Safety of Vedolizumab for Inflammatory Bowel Disease

Journal of Crohn's and colitis(2018)

引用 1|浏览41
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要